more focus on treating Clostridium difficile

June 2013

You'll see more focus on treating Clostridium difficile.

These GI infections are becoming more common and harder to treat.

The risk of recurrence is up to 25% after the first episode...and up to 65% after the second episode.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice More pharmacists will ramp up medication therapy management (MTM) services
Smoking Cessation New labels for OTC nicotine replacement therapy will no longer tell patients they have to stop smoking first
Infectious Diseases more focus on treating Clostridium difficile
Pregnancy Diclegis (dye-CLEE-gis), a "new" Rx drug for morning sickness
Supplements the safety and benefits of L-carnitine
Supplements if enzyme supplements help gas and bloating
Women's Health Osphena (os-FEE-nah, ospemifene) for women with pain during intercourse due to menopause
Insomnia Are non-benzodiazepine hypnotics (zolpidem, etc) really safer than benzos (temazepam, etc) for seniors with insomnia
Gastroenterology more opportunities to help manage gastroparesis
Diabetes more emphasis on preventing and treating hypoglycemia in patients with type 2 diabetes
Dermatology two new topical OTC anti-itch products, Allegra Cooling Relief and Allegra Intensive Relief